Goldenwell Biotech Inc (GWLL) Dividendos

Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The company is headquartered in Solon, Ohio. The company went IPO on 2021-12-07. The firm is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.